Erythromycin Ethylsuccinate
Based on 1 Customer Validation
Erythromycin Ethylsuccinate is an antibiotic useful for the treatment of a number of bacterial infections, has an antimicrobial spectrum similar to or slightly wider than that of penicillin. Erythromycin Ethylsuccinate has antiviral activity against HIV-1.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 79.0%
- No. CAS: 1264-62-6
- Fòrmula: C43H75NO16
- Peso molecular:862.05
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-B0957R
Erythromycin Ethylsuccinate (Standard)Antibiotic -
HY-B1743A
Puromycin dihydrochlorideProtein Synthesis Inhibitor -
HY-17506A
Azithromycin hydrateAntibiotic -
HY-B1743AR
Puromycin dihydrochloride (Standard)Protein Synthesis Inhibitor -
HY-14865B
Omadacycline tosylateAntimicrobial Agent -
HY-17506AR
Azithromycin hydrate (Standard)Antibiotic -
HY-N7139A
Penicillin G benzathineAntibiotic -
HY-14865BR
Omadacycline tosylate (Standard)Antimicrobial Agent
Ver todos los productos específicos de isoformas Antibiotic
More
Actividad biológica
Descripciòn
IC50 & Target
|
HIV-1 |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HSALR transgenic mouse model (obtained by the integration of the DMPK gene)
-
Dosage:100 mg/kg
-
Administration:Oral gavage, p.o., once daily for 21 days
-
Result:Significantly improved missplicing of Clcn1 and Atp2a1 and alleviated myotonia.
-
Animal Model:Swedish Warmblood[1]
-
Dosage:1.25 mg/kg, 0.125 mg/kg, 0.25 mg/kg
-
Administration:Oral gavage (p.o.), once daily for 3-5 days
-
Result:Induced acute colitis, with severe diarrhea, dehydration, fever, and toxemia.
Ensayo clínico
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 1264-62-6
-
Appearance Solid
-
Peso molecular 862.05
-
Fòrmula C43H75NO16
-
Color White to off-white
-
SMILES
O=C(CCC(OCC)=O)O[C@H]([C@H]1N(C)C)[C@](O[C@H](C)C1)([H])O[C@@H]([C@](O)(C[C@H](C([C@@H]([C@@H](O)[C@@]2(O)C)C)=O)C)C)[C@H]([C@@H]([C@H](C(O[C@@H]2CC)=O)C)O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)C
-
Synonyms
Erythromycin ethyl succinate; EES
-
Structure Classification
-
Initial Source
Saccharopolyspora erythraea
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Solvente y solubilidad
In Vitro:
DMSO : ≥ 50 mg/mL (58.00 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Ethanol : ≥ 33.33 mg/mL (38.66 mM)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (2.90 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (280 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Gustafsson A, et al. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J. 1997 Jul;29(4):314-8. [Content Brief]
[2]. Feng YC, et al. Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy. J Pharm Biomed Anal. 2006 May 3;41(2):373-84. [Content Brief]
[3]. Komuro I, et al. Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12509-14. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Ethanol / DMSO | 1 mM | 1.1600 mL | 5.8001 mL | 11.6003 mL | 29.0006 mL |
| 5 mM | 0.2320 mL | 1.1600 mL | 2.3201 mL | 5.8001 mL | |
| 10 mM | 0.1160 mL | 0.5800 mL | 1.1600 mL | 2.9001 mL | |
| 15 mM | 0.0773 mL | 0.3867 mL | 0.7734 mL | 1.9334 mL | |
| 20 mM | 0.0580 mL | 0.2900 mL | 0.5800 mL | 1.4500 mL | |
| 25 mM | 0.0464 mL | 0.2320 mL | 0.4640 mL | 1.1600 mL | |
| 30 mM | 0.0387 mL | 0.1933 mL | 0.3867 mL | 0.9667 mL | |
| DMSO | 40 mM | 0.0290 mL | 0.1450 mL | 0.2900 mL | 0.7250 mL |
| 50 mM | 0.0232 mL | 0.1160 mL | 0.2320 mL | 0.5800 mL |
Erythromycin Ethylsuccinate Related Classifications
HY-B0957 Related Classifications
Powered by Bioz